Though I don't disagree with the stock moving up it is most certainly not due to Zacks which has no value whatsoever. Zacks doesn't even know what MDXG does as evidenced by the discussion in their drivel about the company's products.
rebecca, or should I call you Suraj, or the chubby reporter? Go stick a tampon where the sun don't shine. No one here is interested in your mindless drivel.
rebecca you ignorant sl__t. I have worked in the M&A area for 30 years. When acquisitions are done, models are built based on cash flow and NPVs. I know thats probably heady stuff for a dumb blonde like you but MDXG is already a cash machine and with 85% margins, as sales continue to explode, like your brain trying to figure this out, the cash flow will be off the charts. Enjoy your short beeatch
rebecca you ignorant sl_tt. Why don't you look at AMZN for valuation ideas since they cant even generate any earnings. What is AMZN's market cap? And, by the way, I look for revenues of $400 million for MDXG either in 2016 or the latest 2017, but they will be long gone by then.
earth. if you email me I can send you a good note that really explains everything about ADK. That preferred has been around for a long time. I know some big investors who have had it since issued and of course done very well with it. ADK has been a riky investment due to its balance sheet and poor track record as an operator but its operating days are over as it is almost thru the transition to becoming a REIT, going from hundreds of employees to 10 or less.Once complete, and possibly an acquisition or two to get to critical mass, the new president (an investment banker) along with the CEO can take it to market. Not sure what you mean by the parent company instituting a dividend? There's just one company. Now that the company is almost thru the transtion it is generating a lot of cash and returning to shareholders. About a 5% yield at current price. Once a few more things are done, should be closer to 10% yield. That is not normal for this sector which is why a big REIT will be willing to pay $7+ for it.
Big fan and longtime customer, most recently buying into their new SIP product (which is doing great so far). But, their margin decision on MDXG is puzzling. They have always been the most conservative in general in terms of authorizing margin but this one seems odd..although volitility does play a big part in their decision I know, not just strength of balance sheet and we know all about the volitility of the stock here.
Petit on call. "There have been some hedge funds in the last year that have bet heavily against us. I don't understand it...the real thing that is going to ruin shorts day is when the PR comes out that company X has been acquired by company Y. We are just not a good short candidate"
rent, I just put a link there to trademark info MDXG filed for Epiburn. It was discussed/announced at the ABA Burn conference yesterday in Chicago. Maybe we will get some info Tuesday.
two different things. how bout. Formal aproval won't come for maybe 2 years and that is for the first use for planters F. What the company is looking for is a transition letter that would allow the company to market the micronized (in all uses) pending all BLAs which is something they are not doing now, they merely take orders for it as of now. It would be akin to an admission by the FDA that they messed up the entire process and almost like them saying "we want you to go the BLA route on the micronized but since the product has been used for years not only with no adverse events but also is a grey area whether this should really even require a BLA at all, we will allow you to market it.
Exact comment was " Resolution of the FDA issues with micronized product is nearly complete, which will allow the company to resume promotion of its injectable products, thus re-activating one of the company’s growth drivers."
correct but there were also comments on recent calls that they are nearing completion